Viewing Study NCT04517851


Ignite Creation Date: 2025-12-24 @ 11:56 PM
Ignite Modification Date: 2026-02-24 @ 2:29 PM
Study NCT ID: NCT04517851
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-18
First Post: 2020-08-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Elotuzumab for the Treatment of JAK2-Mutated Myelofibrosis
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelofibrosis Transformation in Essential Thrombocythemia View
None Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase View
None Primary Myelofibrosis View
Keywords: